[1]张春利,王 薇,刘利君,等.寻常型银屑病血浆中CGRP1、VIP水平与PASI评分的相关性分析[J].医学信息,2021,34(13):110-112.[doi:10.3969/j.issn.1006-1959.2021.13.028]
 ZHANG Chun-li,WANG Wei,LIU Li-jun,et al.Correlation Analysis of Plasma Levels of CGRP1,VIP and PASI Score in Patients with Psoriasis Vulgaris[J].Medical Information,2021,34(13):110-112.[doi:10.3969/j.issn.1006-1959.2021.13.028]
点击复制

寻常型银屑病血浆中CGRP1、VIP水平与PASI评分的相关性分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年13期
页码:
110-112
栏目:
论著
出版日期:
2021-07-01

文章信息/Info

Title:
Correlation Analysis of Plasma Levels of CGRP1,VIP and PASI Score in Patients with Psoriasis Vulgaris
文章编号:
1006-1959(2021)13-0110-03
作者:
张春利王 薇刘利君
(1.承德医学院附属医院皮肤病与性病科,河北 承德 067000; 2.天津医科大学总医院总医院滨海医院皮肤科,天津 300450)
Author(s):
ZHANG Chun-liWANG WeiLIU Li-junet al.
(1.Department of Dermatology and Venereology,Affiliated Hospital of Chengde Medical University,Chengde 067000,Hebei,China; 2.Department of Dermatology,Binhai Hospital,General Hospital of Tianjin Medical University,Tianjin 300450,China)
关键词:
寻常型银屑病银屑病皮损面积和严重程度指数降钙基因相关肽血管活性肠肽
Keywords:
Psoriasis vulgarisPsoriasis lesion area and severity indexCalcitonin gene-related peptideVasoactive intestinal peptide
分类号:
R758.63
DOI:
10.3969/j.issn.1006-1959.2021.13.028
文献标志码:
A
摘要:
目的 研究不同严重程度的寻常型银屑病患者外周血中降钙基因相关肽(CGRP)、血管活性肠肽(VIP)表达情况及其与银屑病皮损面积和严重程度指数(PASI)的关系。方法 选取2018年1月~12月于承德医学院附属医院收治的寻常型银屑病患者60例作为研究对象,根据PASI评分将患者分为PV1组(PASI评分<10分)、PV2组(PASI评分10~20分)、PV3组(PASI评分20~30分),另收集同期本院健康体检者20名作为对照组。比较四组血浆中CGRP1和VIP水平,分析PV患者血浆中CGRP1及VIP与PASI评分的相关性。结果 四组血浆CGRP1及VIP表达水平比较,差异有统计学意义(P<0.05),其中PV3组>PV2组>PV1组>对照组;但PV1组与对照组血浆CGRP1、VIP比较,差异无统计学意义(P>0.05);PV2组与PV3组血浆VIP比较,差异无统计学意义(P>0.05)。相关性分析显示,PV患者血浆CGRP1与PASI呈正相关(r=0.7093,P=0.0001),血浆VIP与PASI无相关性(r=0.2289,P=0.7850)。结论 寻常型银屑病患者血浆CGRP1与PASI评分密切相关,可作为辅助评价寻常性银屑病严重程度的相对客观的实验室指标。
Abstract:
Objective To study the expression of calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP) in peripheral blood of patients with psoriasis vulgaris of different severity and their relationship with the area and severity index (PASI) of psoriasis relationship.Methods 60 patients with psoriasis vulgaris who were treated or hospitalized in the Affiliated Hospital of Chengde Medical University from January to December 2018 were selected as the research objects.According to the PASI score, patients are divided into PV1 group (PASI score <10 points), PV2 group (PASI score 10-20 points), PV3 group (PASI score 20-30 points).In addition, 20 healthy subjects in our hospital during the same period were collected as a control group.The plasma levels of CGRP1 and VIP in the four groups were compared, and the correlation between CGRP1 and VIP in the plasma of PV patients and the PASI score was analyzed.Results The plasma CGRP1 and VIP expression levels of the four groups were compared,the differences were statistically significant(P<0.05).Among them, PV3 group>PV2 group>PV1 group>control group;However, there was no significant difference in plasma CGRP1 and VIP between the PV1 group and the control group (P>0.05);There was no significant difference in plasma VIP between the PV2 group and the PV3 group (P>0.05).Correlation analysis showed that plasma CGRP1 in patients with PV was positively correlated with PASI (r=0.7093, P=0.0001), and there was no correlation between plasma VIP and PASI (r=0.2289, P=0.7850).Conclusion Plasma CGRP1 in patients with psoriasis vulgaris is closely related to the PASI score, and can be used as a relatively objective laboratory indicator to assist in evaluating the severity of psoriasis vulgaris.

参考文献/References:

[1]中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南(2018完整版)[J].中华皮肤科杂志,2019,52(10):667-710. [2]Tampa M,Sarbu M,Mitran M,et al.The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis,a Stress-Related Skin Disease[J].Disease Markers,2018(2018):5823684. [3]Singh S,Taylor C,Kornmehl H,et al.Psoriasis and suicidality:A systematic review and meta-analysis[J].Journal of the American Academy of Dermatology,2017,77(3):425-440. [4]Egeberg A,Hansen PR,Gislason GH,et al.Risk of self-harm and nonfatal suicide attempts,and completed suicide in patients with psoriasis:a population-based cohort study[J].British Journal of Dermatology,2016,175(3):493-500. [5]周燕楠.降钙素基因相关肽(CGRP)对人血管内皮细胞活化及分泌趋化因子调节作用的研究[D].首都医科大学,2016. [6]Vegas O,Poligone B,Blackcloud P,et al.Chronic social stress Ameliorates psoriasiform dermatitis through upregulation of the Hypothalamic-Pituitary-Adrenal axis[J].Brain,Behavior,and Immunity,2018(68):238-247. [7]Zhu TH,Nakamura M,Farahnik B,et al.The Role of the Nervous System in the Pathophysiology of Psoriasis:A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury[J].American Journal of Clinical Dermatology,2016,17(3):257-263. [8]Meneguin S,de Godoy NA,Pollo CF,et al.Quality of life of patients living with psoriasis:a qualitative study[J].BMC Dermatology,2020,20(1):22. [9]Ding W,Stohl LL,Wagner JA,et al.Calcitonin Gene-Related Peptide Biases Langerhans Cells toward Th2-Type Immunity[J].J Immunol,2008,181(9):6020-6026. [10]Tuo Y,Guo X,Zhang X,et al.The biological effects and mechanisms of calcitonin gene-related peptide on human endothelial cell[J].Journal of Receptors and Signal Transduction,2013,33(2):114-123. [11]Ding W,Stohl LL,Xu L,et al.Calcitonin Gene-Related Peptide-Exposed Endothelial Cells Bias Antigen Presentation to CD4+ T Cells toward a Th17 Response[J].J Immunol,2016,196(5):2181-2194. [12]Choi JE,Di Nardo A.Skin neurogenic inflammation[J].Seminars in Immunopathology,2018,40(3):249-259. [13]Hu JZ,Billings SD,Yan D,et al.Histologic comparison of tumor necrosis factor-α inhibitor-induced psoriasis and psoriasis vulgaris[J].J Am Acad Dermatol,2020,83(1):71-77.

相似文献/References:

[1]杨 丽,陈 洁,赵怀智,等.针灸治疗寻常型银屑病的临床研究进展[J].医学信息,2018,31(17):54.[doi:10.3969/j.issn.1006-1959.2018.17.017]
 YANG Li,CHEN Jie,ZHAO Huai-zhi,et al.Clinical Research Progress of Acupuncture for Psoriasis Vulgaris[J].Medical Information,2018,31(13):54.[doi:10.3969/j.issn.1006-1959.2018.17.017]
[2]于 浈.银屑病患者前瞻记忆的研究[J].医学信息,2019,32(05):121.[doi:10.3969/j.issn.1006-1959.2019.05.038]
 YU Zhen.Prospective Memory Study in Patients with Psoriasis[J].Medical Information,2019,32(13):121.[doi:10.3969/j.issn.1006-1959.2019.05.038]

更新日期/Last Update: 1900-01-01